Who's who in Grifols, the pharmaceutical firm that acts as a financial institution for the Catalan household | EUROtoday

Get real time updates directly on you device, subscribe now.

In the sport of who's who that Grifols has deployed, the tangle of interconnections that exist between the household, its firm and the funding firm of which they’re half, Scranton, makes the work of analysts troublesome (seen on Thursday in a bump of 35% within the Stock Market after presenting outcomes) and offers wings to the hypothesis of bears like Gotham City. The market is awaiting the decision of the National Securities Market Commission (CNMV), which is interpreted as the ultimate blow for the corporate within the occasion that it’s not favorable. But, in the meantime, the issue that Daniel Yu's signature along with his stories placed on the desk stays unresolved: the ties that unite the complete household community. And who’s inside? From the holding Scranton – which doesn’t formally belong to Grifols, however the place administrators with this final identify immediately management 20% -, to the associated corporations that had been bought to Scranton, BPC Plasma and Haema, the financial institution loans the place the household's money owed are combined, the corporate or these granted to the household firm; In addition to the cash that Grifols lends to the household immediately and even the donations that the holding realizes to NGOs like Probitas or like Fundaci Grifols personal.

The 2023 outcomes revealed that Grifols had lent 5.6 million euros to former president Víctor Grifols Roura final yr., who left workplace in December. The firm solely clarifies that within the month of January this debt was settled, coinciding in time with the Gotham City report, which was revealed on the eighth of that month. There are not any loans to every other Grifols in recent times, nor to every other member of the board of administrators.

On the opposite hand, Grifols has additionally loaned cash to Scrantonafter having bought BPC Plasma and Haema for $538 million simply after its acquisition in 2018. Specifically, The debt quantities to 110 million {dollars}, since, from the preliminary 95 million, final yr that mortgage was expanded by one other 15 million. In different phrases, Grifols lent cash to its shareholder in order that it may purchase its personal corporations, since, it claims, this debt is “related to the payment for the sale” of those two shares. In any case, it might be Grifols who would assume this mortgage within the occasion of non-payment to the banks.

According to what EL MUNDO revealed within the month of January, as well as Eight Spanish entities can have a debt with Scranton of 450 million euros which might be distributed equally between CaixaBank, Banco Santander, BBVA and Banco de Sabadell, along with Bank of America, BNP, HSBC and Commerzbank. There is one other mortgage of 500 million on to Grifols, which was what the European Central Bank (ECB) requested to make clear when the scandal broke in the beginning of the yr.

Scranton, very current within the Gotham City report, has all the time been thought-about the household's property, though they declare that they solely have 20% of the capital immediately. It can also be a shareholder of Grifols, because it holds an 8.6% stake. However, and though Scranton's accounts are in Holland, a few of its administrators are recognized. One of them is lawyer Toms Dag, an advisor to the pharmaceutical firm, who seems as a shareholder in Scranton Enterprises. He can also be one of many founding companions of the Osborne Clarke regulation agency. Within the patrimonial there are two corporations, one specialised in plasma and one other in actual property, Centurin. Among the three prime executives, two are linked to Grifols or its administrators. Jordi Fbregas can also be a founding associate of Osborne Clarke; and Juan Javier Roura joined the group in 1986 and till his departure in 2015, he was vice chairman of Treasury and Risk at Grifols.

On the opposite hand, Grifols yearly fulfills its dedication to distribute 0.7% of pre-tax earnings to a non-profit groupWhat is just not clarified is whether or not it’s Probitas or the Fundaci Grifols itself or a 3rd occasion – the corporate has not responded to this query -, in each circumstances managed by the corporate. The president of the Probitas board is Nria Martín Varnés, co-founder of Osborne Clarke and secretary of the board of administrators of Grifols since 2015. Enrique Grifols Roura, a physician by career, can also be a member.


Grifols recovered simply over 800 million euros of market capitalization yesterday with a rebound of 18%, which isn’t sufficient to compensate for the 35% drop this Thursday after presenting outcomes, which weren’t audited by KPMG. Behind this rise there are as much as three related information that the listed firm revealed yesterday earlier than the tip of the morning by way of the National Securities Market Commission (CNMV) to clarify what it didn’t make clear the day prior to this. The first of them was to substantiate what was mentioned on Thursday, that The operation with Haier for the sale of 20% of Shanghai Raas stays uncomplicatedsurpassed due diligence, and that may shut earlier than the summer season. This cash is essential for Grifols for the reason that 1.8 billion it can obtain will probably be totally used to repay debt. Specifically, the 1,900 million that it has in two maturities in 2025.

The second related reality was to clarify the misunderstanding that occurred on Thursday as a result of a poor expression in English by the board of administrators when it was implied that the money flows (which had been unfavorable in 2023) can be constructive by a number of million within the coming years. The agency expects that from 2025 to 2027 they’ll attain 2,000-2,500 million euros. They will probably be about 5 million because of the affect of some investments (in ImmunoTek) this yr.

And the third communication was to accuse the press that, in keeping with the corporate, “has misinterpreted the accounting treatment” given to the associated corporations, “Haema, AG and BPC Plasma” and to the cost of 266 million euros in dividends that has been made to Scranton, which is the de facto proprietor of those corporations. It ought to be famous that Grifols has not given a press convention or statements to journalists for the reason that scandal broke out on January 8.

“The payment of the dividend is supposedly made by delivering 'Other non-current financial assets' which can be any type of financial investments, other than cash. It is a movement that has not been explained, but possibly involves a financial loss for Grifols' minority shareholders for the same amountsince the counterpart of the liability can only be Own resources, according to our preliminary opinion, based on the confusing and insufficient information available”, level out from Bankinter's Analysis Department. On the opposite hand, Grifols has not paid dividends to its shareholders since 2021 as a result of its excessive debt ranges.